Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762.TW) Stock
—
Valuation
Financials & Margins
Valuation & Return Ratios
Ownership
About Chunghwa Chemical Synthesis & Biotech Co., Ltd.
—
Chunghwa Chemical Synthesis & Biotech Co., Ltd. is led by CEO Chung Hsin Huang, employs 243 people, headquartered in New Taipei City, TW, publicly traded since 2010.
Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762.TW) stock trades at $33.60 with a market capitalization of $2.65B. The stock is valued at a negative price-to-earnings (P/E) ratio of -36.60, reflecting a net loss over the last twelve months, price-to-book of 0.83, price-to-sales of 2.83. Over the past 52 weeks the stock has ranged between $24.20 and $44.75, and currently trades 24.9% below its 52-week high.
On profitability, Chunghwa Chemical Synthesis & Biotech Co., Ltd. generates a return on equity (ROE) of -1.60% (negative, reflecting a net loss), an operating margin of 11.55%, a net profit margin of -5.53%.
Official website: www.ccsb.com.tw
Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762.TW) — frequently asked questions
What is Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762.TW) stock price today?
Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762.TW) is currently trading at $33.60, down 2.18% today.
What is 1762.TW P/E ratio?
Chunghwa Chemical Synthesis & Biotech Co., Ltd.'s P/E ratio is -36.60. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.
What is 1762.TW return on equity (ROE)?
Chunghwa Chemical Synthesis & Biotech Co., Ltd.'s return on equity (ROE) is -1.60%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.
What is Chunghwa Chemical Synthesis & Biotech Co., Ltd.'s market cap?
Chunghwa Chemical Synthesis & Biotech Co., Ltd. has a market capitalization of $2.65B.
Does 1762.TW pay a dividend?
Chunghwa Chemical Synthesis & Biotech Co., Ltd. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.
How much debt does 1762.TW carry?
Chunghwa Chemical Synthesis & Biotech Co., Ltd. has a debt-to-equity ratio of 0.24. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 1762.TW's profit margin?
Chunghwa Chemical Synthesis & Biotech Co., Ltd. reports a net profit margin of -5.53% — the share of revenue left after every cost, including tax and interest.
What sector is 1762.TW in?
Chunghwa Chemical Synthesis & Biotech Co., Ltd. is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 1762.TW listed on?
Chunghwa Chemical Synthesis & Biotech Co., Ltd. trades on TAI under the ticker 1762.TW.
What is 1762.TW's 52-week range?
Over the last year Chunghwa Chemical Synthesis & Biotech Co., Ltd. has traded between $24.20 and $44.75.
Related — Stocks
Popular Stocks
Screens 1762.TW currently matches
On the figures above, Chunghwa Chemical Synthesis & Biotech Co., Ltd. passes the filters for 7 of our ready-made screens, among them Low PB Stocks, Low Debt Stocks, Stocks Under $100. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.